Abeona Therapeutics
Price & Volume
Stats
See more52W Range | $3.93-$7.54 |
Market Cap | $279M |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $400,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$29.2M |
Diluted EPS | $1.21 |
News
See moreYahoo Finance • 10 days ago
Fanconi Anemia Market Research Report 2025-2035: Competitive Growth Driven by Rocket Pharmaceuticals, Foresee, Merck, and Abeona as Gene Therapy and CRISPR-Based Innovations Expand
Yahoo Finance • 16 days ago
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
Yahoo Finance • 21 days ago
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
Yahoo Finance • 25 days ago
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Vishwas Seshadri M.B.A., Ph.D. |
Address | 6555 Carnegie Avenue, Cleveland, OH, United States, 44103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 136 |
